dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Cosentino, Giulia |
dc.contributor.author | Cataldo, Alessandra |
dc.contributor.author | Plantamura, Ilaria |
dc.contributor.author | Nuciforo, Paolo Giovanni |
dc.contributor.author | Ciniselli, Chiara Maura |
dc.contributor.author | Pizzamiglio, Sara |
dc.contributor.author | De Cecco, Loris |
dc.date.accessioned | 2022-06-27T12:01:27Z |
dc.date.available | 2022-06-27T12:01:27Z |
dc.date.issued | 2022-01 |
dc.identifier.citation | Pizzamiglio S, Cosentino G, Ciniselli CM, De Cecco L, Cataldo A, Plantamura I, et al. What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study. Cancer Med. 2022 Jan;11(2):332–9. |
dc.identifier.issn | 2045-7634 |
dc.identifier.uri | https://hdl.handle.net/11351/7731 |
dc.description | HER2; MicroARN; Trastuzumab |
dc.description.sponsorship | This work was supported by a Young Investigator Grant (Ricerca Finalizzata Giovani Ricercatori) from the Italian Ministry of Health to M.V. Iorio (grant no. GR-2016-02361750). |
dc.language.iso | eng |
dc.publisher | Wiley |
dc.relation.ispartofseries | Cancer Medicine;11(2) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Mama - Càncer - Aspectes genètics |
dc.subject | Marcadors tumorals |
dc.subject | Mama - Càncer - Tractament |
dc.subject.mesh | Breast Neoplasms |
dc.subject.mesh | /genetics |
dc.subject.mesh | Neoadjuvant Therapy |
dc.subject.mesh | Biomarkers, Tumor |
dc.title | What if the future of HER2-positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1002/cam4.4449 |
dc.subject.decs | neoplasias de la mama |
dc.subject.decs | /genética |
dc.subject.decs | tratamiento neoadyuvante |
dc.subject.decs | marcadores tumorales |
dc.relation.publishversion | https://doi.org/10.1002/cam4.4449 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Pizzamiglio S, Ciniselli CM] Bioinformatics and Biostatistics Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. [Cosentino G, Cataldo A, Plantamura I] Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. [De Cecco L] Integrated Biology Platform, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. [Nuciforo P] Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain |
dc.identifier.pmid | 34921525 |
dc.identifier.wos | 000731256000001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |